Synopsis
Synopsis
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Amorolfin Hydrochloride
2. Amorolfine
3. Locryl
4. Loceryl
5. Locetar
6. Odenil
7. Ro 14-4767-002
8. Ro-14-4767-002
1. Amorolfine Hcl
2. 78613-38-4
3. Amorolfin
4. Loceryl
5. 106614-68-0
6. Amorolfine (hydrochloride)
7. Amorolfine Hydrochloride [jan]
8. Amorolfine Hydrochloride
9. 741yh7379h
10. 78613-38-4 (hcl)
11. (2r,6s)-2,6-dimethyl-4-(2-methyl-3-(4-(tert-pentyl)phenyl)propyl)morpholine Hydrochloride
12. Amorolfine Hydrochloride (jan)
13. Curanail
14. Locetar
15. Pekiron
16. Odenil
17. Amorolfine (as Hydrochloride)
18. 2,6-dimethyl-4-(2-methyl-3-(4-(tert-pentyl)phenyl)propyl)morpholine Hydrochloride
19. (2r,6s)-2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine;hydrochloride
20. Bekiron
21. Unii-741yh7379h
22. (2r,6s)-rel-2,6-dimethyl-4-(2-methyl-3-(4-(tert-pentyl)phenyl)propyl)morpholine Hydrochloride
23. Pekiron (tn)
24. Mfcd00903738
25. Starbld0005329
26. Schembl36711
27. Mls006010200
28. Ro-14-4767/000
29. Amorolfine Hydrochloride- Bio-x
30. Chembl4303363
31. Amorolfine For System Suitability
32. Chebi:59649
33. Dtxsid80229217
34. Hy-b0238
35. Ac-080
36. Amorolfine Hydrochloride [mi]
37. Mt-861
38. S1676
39. Akos015912323
40. Ccg-213057
41. Amorolfine Hydrochloride [mart.]
42. Amorolfine Hydrochloride [who-dd]
43. As-13295
44. Ba164168
45. Smr004701299
46. Amorolfine Hydrochloride, >=98% (hplc)
47. Sw219285-1
48. Ro-14-4767/002
49. Amorolfine Hydrochloride [ep Monograph]
50. D01720
51. 613a384
52. Q27888046
53. (2r,6s)-2,6-dimethyl-4-(2-methyl-3-(4-tert-pentylphenyl)propyl)morpholine Hydrochloride
54. (2s,6r)-2,6-dimethyl-4-(2-methyl-3-(4-tert-pentylphenyl)propyl)morpholine Hydrochloride
55. (2r,6s)-2,6-dimethyl-4-{2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl}morpholine Hydrochloride
56. (2s,6r)-2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine;hydrochloride
Molecular Weight | 354.0 g/mol |
---|---|
Molecular Formula | C21H36ClNO |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Exact Mass | 353.2485425 g/mol |
Monoisotopic Mass | 353.2485425 g/mol |
Topological Polar Surface Area | 12.5 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 336 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antifungal Agents
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
48
PharmaCompass offers a list of Amorolfine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amorolfine Hydrochloride manufacturer or Amorolfine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amorolfine Hydrochloride manufacturer or Amorolfine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Amorolfine Hydrochloride API Price utilized in the formulation of products. Amorolfine Hydrochloride API Price is not always fixed or binding as the Amorolfine Hydrochloride Price is obtained through a variety of data sources. The Amorolfine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Amorolfin;Curanail;Loceryl;Locetar;Odenil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amorolfin;Curanail;Loceryl;Locetar;Odenil, including repackagers and relabelers. The FDA regulates Amorolfin;Curanail;Loceryl;Locetar;Odenil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amorolfin;Curanail;Loceryl;Locetar;Odenil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amorolfin;Curanail;Loceryl;Locetar;Odenil manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amorolfin;Curanail;Loceryl;Locetar;Odenil supplier is an individual or a company that provides Amorolfin;Curanail;Loceryl;Locetar;Odenil active pharmaceutical ingredient (API) or Amorolfin;Curanail;Loceryl;Locetar;Odenil finished formulations upon request. The Amorolfin;Curanail;Loceryl;Locetar;Odenil suppliers may include Amorolfin;Curanail;Loceryl;Locetar;Odenil API manufacturers, exporters, distributors and traders.
click here to find a list of Amorolfin;Curanail;Loceryl;Locetar;Odenil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Amorolfin;Curanail;Loceryl;Locetar;Odenil DMF (Drug Master File) is a document detailing the whole manufacturing process of Amorolfin;Curanail;Loceryl;Locetar;Odenil active pharmaceutical ingredient (API) in detail. Different forms of Amorolfin;Curanail;Loceryl;Locetar;Odenil DMFs exist exist since differing nations have different regulations, such as Amorolfin;Curanail;Loceryl;Locetar;Odenil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Amorolfin;Curanail;Loceryl;Locetar;Odenil DMF submitted to regulatory agencies in the US is known as a USDMF. Amorolfin;Curanail;Loceryl;Locetar;Odenil USDMF includes data on Amorolfin;Curanail;Loceryl;Locetar;Odenil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Amorolfin;Curanail;Loceryl;Locetar;Odenil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Amorolfin;Curanail;Loceryl;Locetar;Odenil suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Amorolfin;Curanail;Loceryl;Locetar;Odenil Drug Master File in Japan (Amorolfin;Curanail;Loceryl;Locetar;Odenil JDMF) empowers Amorolfin;Curanail;Loceryl;Locetar;Odenil API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Amorolfin;Curanail;Loceryl;Locetar;Odenil JDMF during the approval evaluation for pharmaceutical products. At the time of Amorolfin;Curanail;Loceryl;Locetar;Odenil JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Amorolfin;Curanail;Loceryl;Locetar;Odenil suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Amorolfin;Curanail;Loceryl;Locetar;Odenil Drug Master File in Korea (Amorolfin;Curanail;Loceryl;Locetar;Odenil KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Amorolfin;Curanail;Loceryl;Locetar;Odenil. The MFDS reviews the Amorolfin;Curanail;Loceryl;Locetar;Odenil KDMF as part of the drug registration process and uses the information provided in the Amorolfin;Curanail;Loceryl;Locetar;Odenil KDMF to evaluate the safety and efficacy of the drug.
After submitting a Amorolfin;Curanail;Loceryl;Locetar;Odenil KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Amorolfin;Curanail;Loceryl;Locetar;Odenil API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Amorolfin;Curanail;Loceryl;Locetar;Odenil suppliers with KDMF on PharmaCompass.
A Amorolfin;Curanail;Loceryl;Locetar;Odenil CEP of the European Pharmacopoeia monograph is often referred to as a Amorolfin;Curanail;Loceryl;Locetar;Odenil Certificate of Suitability (COS). The purpose of a Amorolfin;Curanail;Loceryl;Locetar;Odenil CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Amorolfin;Curanail;Loceryl;Locetar;Odenil EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Amorolfin;Curanail;Loceryl;Locetar;Odenil to their clients by showing that a Amorolfin;Curanail;Loceryl;Locetar;Odenil CEP has been issued for it. The manufacturer submits a Amorolfin;Curanail;Loceryl;Locetar;Odenil CEP (COS) as part of the market authorization procedure, and it takes on the role of a Amorolfin;Curanail;Loceryl;Locetar;Odenil CEP holder for the record. Additionally, the data presented in the Amorolfin;Curanail;Loceryl;Locetar;Odenil CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Amorolfin;Curanail;Loceryl;Locetar;Odenil DMF.
A Amorolfin;Curanail;Loceryl;Locetar;Odenil CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Amorolfin;Curanail;Loceryl;Locetar;Odenil CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Amorolfin;Curanail;Loceryl;Locetar;Odenil suppliers with CEP (COS) on PharmaCompass.
A Amorolfin;Curanail;Loceryl;Locetar;Odenil written confirmation (Amorolfin;Curanail;Loceryl;Locetar;Odenil WC) is an official document issued by a regulatory agency to a Amorolfin;Curanail;Loceryl;Locetar;Odenil manufacturer, verifying that the manufacturing facility of a Amorolfin;Curanail;Loceryl;Locetar;Odenil active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Amorolfin;Curanail;Loceryl;Locetar;Odenil APIs or Amorolfin;Curanail;Loceryl;Locetar;Odenil finished pharmaceutical products to another nation, regulatory agencies frequently require a Amorolfin;Curanail;Loceryl;Locetar;Odenil WC (written confirmation) as part of the regulatory process.
click here to find a list of Amorolfin;Curanail;Loceryl;Locetar;Odenil suppliers with Written Confirmation (WC) on PharmaCompass.
Amorolfin;Curanail;Loceryl;Locetar;Odenil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amorolfin;Curanail;Loceryl;Locetar;Odenil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amorolfin;Curanail;Loceryl;Locetar;Odenil GMP manufacturer or Amorolfin;Curanail;Loceryl;Locetar;Odenil GMP API supplier for your needs.
A Amorolfin;Curanail;Loceryl;Locetar;Odenil CoA (Certificate of Analysis) is a formal document that attests to Amorolfin;Curanail;Loceryl;Locetar;Odenil's compliance with Amorolfin;Curanail;Loceryl;Locetar;Odenil specifications and serves as a tool for batch-level quality control.
Amorolfin;Curanail;Loceryl;Locetar;Odenil CoA mostly includes findings from lab analyses of a specific batch. For each Amorolfin;Curanail;Loceryl;Locetar;Odenil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amorolfin;Curanail;Loceryl;Locetar;Odenil may be tested according to a variety of international standards, such as European Pharmacopoeia (Amorolfin;Curanail;Loceryl;Locetar;Odenil EP), Amorolfin;Curanail;Loceryl;Locetar;Odenil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amorolfin;Curanail;Loceryl;Locetar;Odenil USP).